Gabapentinoids confer survival benefit in human glioblastoma
Joshua D. Bernstock(Brigham and Women's Hospital), Shawn L. Hervey‐Jumper(University of California, San Francisco), Pierpaolo Peruzzi(Brigham and Women's Hospital), Jakob V. E. Gerstl(Brigham and Women's Hospital), Cesar Nava Gonzales(University of California, San Francisco), Timothy R. Smith(Brigham and Women's Hospital), Philip Heesen(Brigham and Women's Hospital), E. Antonio Chiocca(Center for Cancer Research), Rania A. Mekary(Brigham and Women's Hospital), Pablo A. Valdés(The University of Texas Medical Branch at Galveston), Kristina Grieco(Brigham and Women's Hospital), Scellig Stone(Boston Children's Hospital), Anna B. Lebouille-Veldman(Brigham and Women's Hospital), Yazmín Odia(Baptist Hospital of Miami), Minesh P. Mehta(Columbia University), Bryan D. Choi(Harvard University), Omar Arnaout(Brigham and Women's Hospital), Mulki Mehari(University of California, San Francisco), David M. Meredith(Brigham and Women's Hospital), Harshit Arora(University of Kentucky), Lennard Spanehl(Brigham and Women's Hospital), Mikias Negussie(University of California, San Francisco), John de Groot(University of California, San Francisco), Andy Daniel(University of California, San Francisco), Saef Izzy(Brigham and Women's Hospital), Matthew D. Hall(Baptist Hospital of Miami), Florian Geßler(University of Rostock), Jasleen Kaur(University of California, San Francisco), Yi Lu(Brigham and Women's Hospital), Vardhaan Ambati(University of California, San Francisco), Gregory K. Friedman(The University of Texas MD Anderson Cancer Center), Youssef Sibih(University of California, San Francisco), Sena Oten(University of California, San Francisco), Jason Chen(Brigham and Women's Hospital), Abraham Dada(University of California, San Francisco), Saritha Krishna(City College of San Francisco), Aymen Kabir(University of California, San Francisco), Benjamin Johnston(Brigham and Women's Hospital)
Cited by 15
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k